Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Müller

Showing results (51-60 of 308) with videos related to

Pageof 31
Sort By:
Aging Clinical and Experimental Research|December 10, 2009
Limitations of the past and latest evolutions of home monitoring: arrhythmia electrograms transmitted automatically improve the efficacy of remote monitoringSebastian Spencker, Nalan Coban, Lydia Koch, et al.
BMJ Open|March 15, 2023
Methods for assessing guideline adherence for invasive procedures in the care of chronic coronary artery disease: a scoping reviewHannah Kentenich, Dirk Müller, Bastian Wein, et al.
Deutsche Medizinische Wochenschrift (1946)|September 20, 2022
[Triglycerides - assessment as risk factor and therapeutic goals]Martin Merkel, Dirk Müller-Wieland, Ulrich Laufs, et al.
Pharmacoeconomics|May 23, 2012
Cost effectiveness of rituximab for non-Hodgkin's lymphoma: a systematic reviewPhilipp W P Auweiler, Dirk Müller, Stephanie Stock, et al.
Thrombosis Journal|February 10, 2016
Venous thromboembolism and persistent pulmonary hypertension in cancer patients: a cross-sectional studySiegfried Wieshammer, Jens Dreyhaupt, Dirk Müller, et al.
Oncology|February 13, 2016
Limitations of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Disease among Cancer Patients Who Present with Cardiac or Pulmonary SymptomsSiegfried Wieshammer, Jens Dreyhaupt, Dirk Müller, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 1, 2020
Predictive modeling to identify potential participants of a disease management program hypertensionPamela Lenti, Stefan Kottmair, Stephanie Stock, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 24, 2008
Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failureSebastian Spencker, Nalan Coban, Lydia Koch, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 14, 2014
Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homesDirk Müller, Lisa Borsi, Claudia Stracke, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2014
Osteoporosis in German men: a cost-of-illness studySabine Berghaus, Dirk Müller, Afschin Gandjour, et al.
Pageof 31

Showing results (51-60 of 308) with videos related to

Sort By:
Pageof 31
Aging Clinical and Experimental Research|December 10, 2009
Limitations of the past and latest evolutions of home monitoring: arrhythmia electrograms transmitted automatically improve the efficacy of remote monitoringSebastian Spencker, Nalan Coban, Lydia Koch, et al.
BMJ Open|March 15, 2023
Methods for assessing guideline adherence for invasive procedures in the care of chronic coronary artery disease: a scoping reviewHannah Kentenich, Dirk Müller, Bastian Wein, et al.
Deutsche Medizinische Wochenschrift (1946)|September 20, 2022
[Triglycerides - assessment as risk factor and therapeutic goals]Martin Merkel, Dirk Müller-Wieland, Ulrich Laufs, et al.
Pharmacoeconomics|May 23, 2012
Cost effectiveness of rituximab for non-Hodgkin's lymphoma: a systematic reviewPhilipp W P Auweiler, Dirk Müller, Stephanie Stock, et al.
Thrombosis Journal|February 10, 2016
Venous thromboembolism and persistent pulmonary hypertension in cancer patients: a cross-sectional studySiegfried Wieshammer, Jens Dreyhaupt, Dirk Müller, et al.
Oncology|February 13, 2016
Limitations of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Disease among Cancer Patients Who Present with Cardiac or Pulmonary SymptomsSiegfried Wieshammer, Jens Dreyhaupt, Dirk Müller, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|July 1, 2020
Predictive modeling to identify potential participants of a disease management program hypertensionPamela Lenti, Stefan Kottmair, Stephanie Stock, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 24, 2008
Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failureSebastian Spencker, Nalan Coban, Lydia Koch, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 14, 2014
Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homesDirk Müller, Lisa Borsi, Claudia Stracke, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2014
Osteoporosis in German men: a cost-of-illness studySabine Berghaus, Dirk Müller, Afschin Gandjour, et al.
Pageof 31